Based on mouse xenograft models, CLL was found to be associated with upregulated USP7 that contributed to aberrant homologous recombination repair, and sensitized p53-deficient, chemotherapy-resistant CLL to clinical doses of chemotherapeutic agents. Here, USP7 is linked to B-cell chronic lymphocytic leukemia.